ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

Breast Density As Important As Age In Determining Risk

September 29, 2006

Obey Questions NCI honesty, Transfers IARC Monograph Support To NIH

October 15, 1982

Bush Nominates VA Official For HHS Deputy Secretary.

March 30, 2001

IOM Panel Suggest Ways To Fund More Training, Construction

November 9, 1990

Study Reveals Racial Disparities In Surgical Prostate Care

August 31, 2012

In Brief: House Subcommittee Adds 15-17% to NIH 1987 Budget; NCI to Fund Lombardi, KY Centers

July 4, 1986